Survival in commercially insured multiple sclerosis patients and comparator subjects in the U.S.

Multiple Sclerosis and Related Disorders

Volumn 3, Issue 3, 2014, Pages 364-371

  Kaufman, D W ^a   Reshef, S ^b   Golub, H L ^c,d   Peucker, M ^c   Corwin, M J ^a,c   Goodin, D S ^e   Knappertz, V ^b,f,g   Pleimes, D ^b   Cutter, G ^h  

^a BOSTON UNIVERSITY   (United States)

^b BAYER CORPORATION   (United States)

^c Care Safe LLC   (United States)

^d HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f HEINRICH HEINE UNIVERSITY   (Germany)

^g TEVA PHARMACEUTICALS   (Israel)

^h UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Cohort studies; Epidemiology; Multiple sclerosis; Natural history studies; Survival

Indexed keywords

ADULT; AGE; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DATA BASE; FEMALE; HEALTH CARE SYSTEM; HEALTH INSURANCE; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE SCLEROSIS; RETROSPECTIVE STUDY; SEX DIFFERENCE; SURVIVAL; UNITED STATES;

EID: 84896545196     PISSN: 22110348     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.msard.2013.12.003     Document Type: Article

References (27)

1. Adams PF, Heyman KM, Vickerie JL. Summary health statistics for the U.S. population: National Health Interview Survey, 2008. National Center for Health Statistics, Vital Health Stat. 2009;10.
2. Anderson DW, Ellenberg JH, Leventhal CM, Reingold SC, Rodriguez M, Silberberg DH. Revised estimate of the prevalence of multiple sclerosis in the United States. Ann Neurol 1992;31:333-6.
3. Bronnum-Hansen H, Koch-Henriksen N, Hyllested K. Survival of patients with multiple sclerosis in Denmark: a nationwide, long-term epidemiologic survey. Neurology 1994;44:1901-7. (Pubitemid 24319218)
4. Bronnum-Hansen H, Koch-Henriksen N, Stenager E. Trends in survival and cause of death in Danish patients with multiple sclerosis. Brain 2004;127:844-50. (Pubitemid 38478529)
5. Centers for Disease Control and Prevention. National Death Index; 2013 [accessed January 2013, at 〈http://www.cdc.gov/nchs/ndi.htm〉].
6. Centers for Disease Control and Prevention NCfHS. Compressed Mortality File 1979-1998. CDC WONDER On-line Database, compiled from Compressed Mortality File CMF 1968-1988, Series 20, No. 2A, 2000 and CMF 1989-1998, Series 20, No. 2E, 2003; 2011a [accessed August 31, 2011, at 〈http://wonder.cdc.gov/cmf- icd9.html〉].
7. Centers for Disease Control and Prevention NCfHS. Compressed Mortality File 1999-2007. CDC WONDER On-line Database, compiled from Compressed Mortality File 1999-2007 Series 20 No. 2M, 2010; 2011b [accessed August 31, 2011, at 〈http://wonder.cdc.gov/cmf-icd10.html〉].
8. Compston A, Coles A. Multiple sclerosis. Lancet 2008;372:1502-17.
9. Confavreux C. Defining the natural history of MS: the need for complete data and rigorous definitions. Mult Scler 2008;14:289-91. (Pubitemid 351676422)
10. Confavreux C, Vukusic S, Moreau T, Adeleine P. Relapses and progression of disability in multiple sclerosis. N Engl J Med 2000;343:1430-8.
11. Ekestern E, Lebhart G. Mortality from multiple sclerosis in Austria 1970-2001: dynamics, trends, and prospects. Eur J Neurol 2004;11:511-20. (Pubitemid 39062088)
12. Goodin DS, Reder AT, Ebers GC, Cutter G, Kremenchutzky M, Oger J, et al. Survival in MS: a randomized cohort study 21 years after the start of the pivotal IFNbeta-1b trial. Neurology 2012;78:1315-22.
13. Grytten Torkildsen N, Lie SA, Aarseth JH, Nyland H, Myhr KM. Survival and cause of death in multiple sclerosis: results from a 50-year follow-up in Western Norway. Mult Scler 2008;14:1191-8.
14. Hirst C, Swingler R, Compston DA, Ben-Shlomo Y, Robertson NP. Survival and cause of death in multiple sclerosis: a prospective population-based study. J Neurol Neurosurg Psychiatry 2008;79: 1016-21.
15. Kingwell E, van der Kop M, Zhao Y, Shirani A, Zhu F, Oger J, et al. Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada. J Neurol Neurosurg Psychiatry 2012;83:61-6.
16. Koch-Henriksen N, Bronnum-Hansen H, Stenager E. Underlying cause of death in Danish patients with multiple sclerosis: results from the Danish Multiple Sclerosis Registry. J Neurol Neurosurg Psychiatry 1998;65:56-9. (Pubitemid 28302357)
17. Lo AC, Hadjimichael O, Vollmer TL. Treatment patterns of multiple sclerosis patients: a comparison of veterans and non-veterans using the NARCOMS registry. Mult Scler 2005;11:33-40. (Pubitemid 40259972)
18. National Center for Health Statistics. NDI User's Guide (Draft 10/06/09): National Center for Health Statistics; 2009.
19. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med 2000;343:938-52.
20. OptumInsight. OptumInsight Retrospective Database; 2013 [accessed January 2013, at 〈http://www.optuminsight.com/life-sciences/solutions/real-world- evidence/data-assets/retrospective-database/overview/〉].
21. Ragonese P, Aridon P, Mazzola MA, Callari G, Palmeri B, Famoso G, et al. Multiple sclerosis survival: a population-based study in Sicily. Eur J Neurol 2010;17:391-7.
22. Reshef S, Cutter G, Golub HL, Kaufman DW, Brueckner A. Mortality in multiple sclerosis in the United States (MIMS-US): a retrospective, cohort study of survival and mortality trends. Annual Meeting of American Academy of Neurology, New Orleans2012.
23. Riise T, Gronning M, Aarli JA, Nyland H, Larsen JP, Edland A. Prognostic factors for life expectancy in multiple sclerosis analysed by Cox-models. J Clin Epidemiol 1988;41:1031-6. (Pubitemid 19002072)
24. Sadovnick AD, Ebers GC, Wilson RW, Paty DW. Life expectancy in patients attending multiple sclerosis clinics. Neurology 1992;42:991-4.
25. Smestad C, Sandvik L, Celius EG. Excess mortality and cause of death in a cohort of Norwegian multiple sclerosis patients. Mult Scler 2009;15:1263-70.
26. Social Security Administration. Social Security's Death Master File; 2013 [accessed January 2013, at 〈http://ssa-custhelp.ssa.gov/app/answers/ detail/a-id/149/~/social-security0s-death-master-file〉].
27. Suissa S. Immortal time bias in pharmaco-epidemiology. Am J Epidemiol 2008;167:492-9.